Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2101
PUT
AES
AES
$10.6B
| $4.47M | ﹤0.01% |
300,000
| – | – |
2025 Q3
4 quarters
|
|
2102
CALL
Seagate
STX
$127B
| $4.43M | ﹤0.01% |
+4,800
| New | +$4.1M |
2026 Q3
0 quarters
|
|
2103
Sony
SONY
$154B
| $4.42M | ﹤0.01% |
187,786
+118,379
| +171% | +$2.71M |
2013 Q2
53 quarters
|
|
2104
Replimune Group
REPL
$2.06B
| $4.41M | ﹤0.01% |
332,977
+105,914
| +47% | +$1.34M |
2018 Q3
32 quarters
|
|
2105
PUT
United Microelectronic
UMC
$40.3B
| $4.41M | ﹤0.01% |
+180,000
| New | +$3.85M |
2026 Q3
0 quarters
|
|
2106
RH
RH
$2.57B
| $4.41M | ﹤0.01% |
36,189
+16,297
| +82% | +$2.58M |
2013 Q2
53 quarters
|
|
2107
Envista
NVST
$4.06B
| $4.39M | ﹤0.01% |
187,127
+155,744
| +496% | +$4.13M |
2022 Q1
18 quarters
|
|
2108
CALL
Howmet Aerospace
HWM
$89.1B
| $4.39M | ﹤0.01% |
+19,400
| New | +$5.11M |
2026 Q3
0 quarters
|
|
2109
Atlantic Union Bankshares
AUB
$5.56B
| $4.38M | ﹤0.01% |
115,442
+47,278
| +69% | +$1.94M |
2016 Q1
42 quarters
|
|
2110
Ducommun
DCO
$2.19B
| $4.38M | ﹤0.01% |
25,518
-3,562
| -12% | -$637K |
2013 Q2
53 quarters
|
|
2111
American Superconductor
AMSC
$1.25B
| $4.37M | ﹤0.01% |
150,120
+142,649
| +1,909% | +$4.47M |
2016 Q1
42 quarters
|
|
2112
Nurix Therapeutics
NRIX
$1.78B
| $4.36M | ﹤0.01% |
183,852
+161,370
| +718% | +$4.02M |
2022 Q1
18 quarters
|
|
2113
Dauch Corp
DCH
$1.1B
| $4.35M | ﹤0.01% |
833,336
-714,439
| -46% | -$4.25M |
2013 Q2
53 quarters
|
|
2114
Evommune Inc
EVMN
$313M
| $4.35M | ﹤0.01% |
526,560
+347,830
| +195% | +$4.17M |
2026 Q1
2 quarters
|
|
2115
Axcelis
ACLS
$3.43B
| $4.34M | ﹤0.01% |
33,055
+18,523
| +127% | +$2.37M |
2017 Q1
38 quarters
|
|
2116
Brookfield Renewable
BEP
$9.23B
| $4.32M | ﹤0.01% |
153,612
+152,371
| +12,278% | +$4.86M |
2020 Q3
24 quarters
|
|
2117
NCR Atleos
NATL
$3.56B
| $4.32M | ﹤0.01% |
95,647
-39,196
| -29% | -$1.81M |
2023 Q4
11 quarters
|
|
2118
CALL
Owens Corning
OC
$9.44B
| $4.32M | ﹤0.01% |
+37,000
| New | +$5.17M |
2026 Q3
0 quarters
|
|
2119
DXP Enterprises
DXPE
$2.4B
| $4.31M | ﹤0.01% |
23,799
+21,821
| +1,103% | +$3.91M |
2016 Q2
41 quarters
|
|
2120
CALL
Unity
U
$22B
| $4.31M | ﹤0.01% |
+105,200
| New | +$4.04M |
2026 Q3
0 quarters
|
|
2121
Coursera
COUR
$930M
| $4.31M | ﹤0.01% |
868,012
+91,322
| +12% | +$513K |
2022 Q1
18 quarters
|
|
2122
Hinge Health
HNGE
$9.8B
| $4.3M | ﹤0.01% |
44,199
-164,234
| -79% | -$14.4M |
2025 Q3
4 quarters
|
|
2123
Cellebrite
CLBT
$3.19B
| $4.29M | ﹤0.01% |
380,901
+358,367
| +1,590% | +$4.77M |
2023 Q2
13 quarters
|
|
2124
CALL
Enphase Energy
ENPH
$3.74B
| $4.29M | ﹤0.01% |
130,000
| – | – |
2025 Q2
5 quarters
|
|
2125
C3.ai
AI
$1.96B
| $4.29M | ﹤0.01% |
389,976
+142,869
| +58% | +$1.41M |
2022 Q1
18 quarters
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.